• Recursion Pharmaceuticals secures $121M in Series C funding biospectrumasia
    July 17, 2019
    The new financing will support Recursion’s continued build-out of its machine learning-enabled drug discovery platform alongside new capabilities designed to radically accelerate new chemical entity chemistry and predict safety pharmacology
PharmaSources Customer Service